Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Work In Process (2016 - 2025)

Historic Work In Process for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $29.2 million.

  • Phibro Animal Health's Work In Process rose 1099.8% to $29.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $29.2 million, marking a year-over-year increase of 1099.8%. This contributed to the annual value of $28.0 million for FY2025, which is 1881.95% up from last year.
  • According to the latest figures from Q4 2025, Phibro Animal Health's Work In Process is $29.2 million, which was up 1099.8% from $25.8 million recorded in Q3 2025.
  • Phibro Animal Health's Work In Process' 5-year high stood at $29.2 million during Q4 2025, with a 5-year trough of $10.1 million in Q3 2021.
  • Its 5-year average for Work In Process is $20.8 million, with a median of $23.0 million in 2023.
  • In the last 5 years, Phibro Animal Health's Work In Process tumbled by 273.8% in 2021 and then surged by 7297.32% in 2022.
  • Over the past 5 years, Phibro Animal Health's Work In Process (Quarter) stood at $11.9 million in 2021, then skyrocketed by 68.34% to $20.0 million in 2022, then grew by 25.27% to $25.1 million in 2023, then increased by 5.05% to $26.3 million in 2024, then increased by 11.0% to $29.2 million in 2025.
  • Its last three reported values are $29.2 million in Q4 2025, $25.8 million for Q3 2025, and $28.0 million during Q2 2025.